The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles

Journal of Virology

Volumn 76, Issue 3, 2002, Pages 1015-1024

  Müller, Barbara ^a   Patschinsky, Tilo ^a   Kräusslich, Hans Georg ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; GAG PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATE; PHOSPHOPROTEIN; PROTEIN P6; SERINE; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ARTICLE; ENDOCYTOSIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; VIRION; VIRUS CELL INTERACTION; VIRUS PARTICLE;

EID: 0036145336     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.3.1015-1024.2002     Document Type: Article

References (68)

1. Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites
2. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates
3. Polypeptides of Mason-Pfizer monkey virus. I. Synthesis and processing of the gag-gene products
4. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA
5. In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain
6. Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles
7. Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection
8. Phosphoproteins of vesicular stomatitis virus: Identity and interconversion of phosphorylated forms
9. Distribution of phosphoserine, phosphothreonine and phosphotyrosine in proteins of vesicular stomatitis virus
10. Protein kinase C-mediated phosphorylation of HIV-I nef in human cell lines
11. The human immunodeficiency virus rev protein is a nuclear phosphoprotein
12. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras
13. Transcriptional regulation by MAP kinases
14. Gag exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins
15. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions
16. HIV-1 infection of non-dividing cells: Evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import
17. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator
18. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release
19. HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product
20. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: Implications for viral budding
21. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding
22. Phosphorylation of the rev gene product of human immunodeficiency virus type 1
23. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type1: Posttranslational modifications, proteolytic processings, and complete amino acid sequences
24. Gettin' down with ubiquitin: Turning off cell-surface receptors, transporters and channels
25. Amiloride sensitive Na channels
26. Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease
27. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase
28. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release
29. Degradation of connexin43 gap junctions involves both the proteasome and the lysosome
30. Regulation of gap junctions by phosphorylation of connexins
31. Function of WW domains as phosphoserine- or phosphothreonine-binding modules
32. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR
33. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5
34. The gag gene products of human immunodeficiency virus type 1: Alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative Gag precursors
35. Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than Gag and is phosphorylated in infected cells
36. The major site of phosphorylation within the Rous sarcoma virus MA protein is not required for replication
37. Gag protein of Moloney murine leukemia virus
38. Gag protein produces a mutant that fails to package its envelope protein
39. Ubiquitination of HIV-1 and MuLV Gag
40. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins
41. Ubiquitin is part of the retrovirus budding machinery
42. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein
43. Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly
44. Rational design of peptide-based HIV proteinase inhibitors
45. Tricine-sodium dodecyl sulfatepolyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa
46. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2
47. HIV-1 particle release mediated by Vpu is distinct from that mediated by p6
48. The genome-associated, specific RNA binding proteins of avian and mammalian type C viruses
49. Phosphorylation of murine type C viral p12 proteins regulates their extent of binding to the homologous viral RNA
50. Differential effects of protein kinase C on the levels of epithelial Na+ channel subunit proteins
51. A role for ubiquitin ligase recruitment in retrovirus release
52. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein
53. Synthesis, assembly and processings of viral proteins
54. Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24
55. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag
56. Ubiquitin in retrovirus assembly: Actor or bystander?
57. Structural basis of inhibitor selectivity in MAP kinases
58. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase
59. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1
60. An assembly domain of the Rous sarcoma virus Gag protein required late in budding
61. gag late assembly domain
62. Phosphorylation of Vif and its role in HIV-1 replication
63. A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release
64. Gag domain result in reduced retention of Pol proteins during virus assembly
65. Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle
66. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses
67. Phosphorylation of human immunodeficiency virus type 1 Vpr regulates cell cycle arrest